XML 30 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stockholders' Equity - Summary of the Company's Stock Option Activity under Equity Incentive Plans (Detail)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2017
USD ($)
$ / shares
shares
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Options Available for Grant, Beginning Balance 549,000
Options Available for Grant, Options authorized 2,000,000
Options Available for Grant, Options granted (2,120,000)
Options Available for Grant, Options forfeited 361,000
Options Available for Grant, Ending Balance 790,000
Options Outstanding, Beginning Balance 4,177,000
Options Outstanding, Options granted 2,120,000
Options Outstanding, Options forfeited (361,000)
Options Outstanding, Ending Balance 5,936,000
Options Outstanding, Vested and exercisable 1,557,000
Options Outstanding, Vested and expected to vest, Ending Balance 4,394,000
Options Outstanding, Unvested 4,379,000
Weighted Average Exercise Price, Beginning Balance | $ / shares $ 1.47
Weighted Average Exercise Price, Options granted | $ / shares 0.40
Weighted Average Exercise Price, Options forfeited | $ / shares 1.19
Weighted Average Exercise Price, Ending Balance | $ / shares 1.11
Weighted Average Exercise Price, Vested and exercisable | $ / shares 1.68
Weighted Average Exercise Price, Vested and expected to vest, Ending Balance | $ / shares 1.04
Weighted Average Exercise Price, Unvested | $ / shares $ 0.91
Weighted Average Remaining Contractual Life, Beginning Balance 8 years 1 month 21 days
Weighted Average Remaining Contractual Life, Ending Balance 8 years 7 months 2 days
Weighted Average Remaining Contractual Life, Vested and exercisable 7 years 7 months 21 days
Weighted Average Remaining Contractual Life, Vested and expected to vest, Ending Balance 8 years 4 months 28 days
Aggregate Intrinsic Value | $ $ 933
Aggregate Intrinsic Value, Vested and exercisable | $ 55
Aggregate Intrinsic Value, Vested and expected to vest, Ending Balance | $ $ 600